N.K.P. Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-05-2024
- Paid Up Capital ₹ 8.00 M
as on 15-05-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 31.87 Cr
as on 15-05-2024
- Satisfied Charges ₹ 1.85 Cr
as on 15-05-2024
- Revenue 22.50%
(FY 2023)
- Profit -50.91%
(FY 2023)
- Ebitda -26.90%
(FY 2023)
- Net Worth 11.62%
(FY 2023)
- Total Assets 17.93%
(FY 2023)
About N.K.P. Pharma
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹31.87 Cr. The company has closed loans amounting to ₹1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hitesh Mevada and Darshan Mevada serve as directors at the Company.
- CIN/LLPIN
U01403GJ2008PTC055212
- Company No.
055212
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does N.K.P. Pharma Private Limited offer?
N.K.P. Pharma Private Limited offers a wide range of products and services, including Seal Machines, Marking and Stamping Machines, Labelling Machines, Pharmaceutical Machines, Vial Washing Machine, Inspection Systems, Bottling Plant, Capping Machine, Stoppering Machine, Strapping & Sealing Machines.
Who are the key members and board of directors at N.K.P. Pharma?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hitesh Mevada | Managing Director | 08-Oct-2008 | Current |
Darshan Mevada | Managing Director | 08-Oct-2008 | Current |
Board Members(0)
Name | Designation | Appointment Date | Status |
---|
Financial Performance of N.K.P. Pharma.
N.K.P. Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.5% increase. The company also saw a substantial fall in profitability, with a 50.91% decrease in profit. The company's net worth Soared by an impressive increase of 11.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of N.K.P. Pharma?
In 2023, N.K.P. Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sterileair Solution Technologies LlpActive 7 years 7 months
Hitesh Mevada and Darshan Mevada are mutual person
- Aseptic Technocraft Private LimitedActive 7 years 4 months
Hitesh Mevada and Darshan Mevada are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 May 2023 | ₹9.99 Cr | Open |
Axis Bank Limited Creation Date: 27 Apr 2010 | ₹10.94 Cr | Open |
Axis Bank Limited Creation Date: 18 Mar 2010 | ₹10.94 Cr | Open |
How Many Employees Work at N.K.P. Pharma?
Unlock and access historical data on people associated with N.K.P. Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N.K.P. Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N.K.P. Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.